SAN ANTONIO, Jan. 26, 2012 /PRNewswire/ -- Mission Pharmacal Company
announces the recent formation of Alamo Pharma Services. This new business
unit, a wholly owned subsidiary of Mission, will provide pharmaceutical sales
teams with operational and human resources (HR) support. Alamo will be
headquartered in Doylestown, Pennsylvania, expanding Mission's Northeastern
United States presence, which also includes the company's Commercial Group
operations and BioComp Pharma, Mission's lifecycle management and generics
company.
"Alamo is an outgrowth of my grandfather, H.N. Walsdorf's, longstanding
commitment to service excellence. The organization was created to be a
strategic partner for the Mission sales teams, providing best-in-class
operational support," notes Neill Walsdorf Jr, president of Mission Pharmacal
Company. "Alamo enables Mission to take advantage of ... (more)
CARY, NC -- (Marketwire) -- 01/26/12 -- Cornerstone Therapeutics (NASDAQ:
CRTX), a specialty pharmaceutical company focused on acquiring, developing
and commercializing proprietary products for the hospital and respiratory
markets, announced a new analysis published in the eFirst Pages section of
the Pediatrics website reporting significant benefits in mortality rate and
the need for redosing when treating neonatal respiratory distress syndrome
(RDS) with Cornerstone's CUROSURF® (poractant alfa) Intratracheal
Suspension(1). The objective of the independently performed meta-analys... (more)
Nuvon, Inc. (www.nuvon.com), the leader in next generation medical device
connectivity and interoperability solutions, today announced that Virtua has
gone live with the first phase of its enterprise-wide device connectivity
infrastructure starting with connectivity to the Picis Peri-Operative System
utilizing Nuvon’s standards-based, open architecture VEGA™ System.
Virtua is a comprehensive healthcare system headquartered in Marlton, N.J.
and includes four hospitals, an ambulatory care center in Camden and a wide
range of other services, including health and wellness centers,
r... (more)
NEW YORK, Jan. 25, 2012 /PRNewswire/ -- Myca Health Inc. announced today
that in the past month primary care practices serving over 10,000 patients
have contracted to implement the Hello Health® Patient Management platform.
The company recently signed agreements with family practice, internal
medicine, pediatric and integrative medicine practices in five states. Hello
Health is a free Patient Management platform integrating an electronic health
record, an online patient health portal and a suite of secure, web-based
communication tools designed to connect patients with the... (more)
CLEVELAND, Jan. 24, 2012 /PRNewswire/ -- Physicians at University Hospitals
(UH) Case Medical Center enrolled their first patient in LEVANT 2, a global,
multicenter, randomized clinical trial evaluating the safety and efficacy of
the Moxy™ Drug Coated Balloon for the treatment of peripheral arterial
disease (PAD).
Co-investigators Sahil Parikh, MD, Michael Cunningham MD, and Vikram
Kashyap, MD, with UH Harrington-McLaughlin Heart & Vascular Institute at UH
Case Medical Center, were the first physicians to successfully implant the
device in a patient.
LEVANT 2, sponsored by m... (more)